Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation.

Castroviejo-Bermejo M, Cruz C, Llop-Guevara A, Gutiérrez-Enríquez S, Ducy M, Ibrahim YH, Gris-Oliver A, Pellegrino B, Bruna A, Guzmán M, Rodríguez O, Grueso J, Bonache S, Moles-Fernández A, Villacampa G, Viaplana C, Gómez P, Vidal M, Peg V, Serres-Créixams X, Dellaire G, Simard J, Nuciforo P, Rubio IT, Dientsmann R, Barrett JC, Caldas C, Baselga J, Saura C, Cortés J, Déas O, Jonkers J, Masson JY, Cairo S, Judde JG, O'Connor MJ, Díez O, Balmaña J, Serra V.

EMBO Mol Med. 2018 Oct 30. pii: e9172. doi: 10.15252/emmm.201809172. [Epub ahead of print]

2.

Percutaneous ultrasound guided vacuum-assisted excision of benign breast lesions: A learning curve to assess outcomes.

Salazar JP, Miranda I, de Torres J, Rus MN, Espinosa-Bravo M, Esgueva A, Salvador R, Rubio IT.

Br J Radiol. 2018 Oct 25:20180626. doi: 10.1259/bjr.20180626. [Epub ahead of print]

PMID:
30359092
3.

ASO Author Reflections: Moving Forward De-escalation of Axillary Surgery After Neoadjuvant Treatment in Breast Cancer.

Rubio IT.

Ann Surg Oncol. 2018 Oct 3. doi: 10.1245/s10434-018-6849-z. [Epub ahead of print] No abstract available.

PMID:
30284130
4.

Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy.

Weber WP, Haug M, Kurzeder C, Bjelic-Radisic V, Koller R, Reitsamer R, Fitzal F, Biazus J, Brenelli F, Urban C, Paulinelli RR, Blohmer JU, Heil J, Hoffmann J, Matrai Z, Catanuto G, Galimberti V, Gentilini O, Barry M, Hadar T, Allweis TM, Olsha O, Cardoso MJ, Gouveia PF, Rubio IT, de Boniface J, Svensjö T, Bucher S, Dubsky P, Farhadi J, Fehr MK, Fulco I, Ganz-Blättler U, Günthert A, Harder Y, Hauser N, Kappos EA, Knauer M, Landin J, Mechera R, Meani F, Montagna G, Ritter M, Saccilotto R, Schwab FD, Steffens D, Tausch C, Zeindler J, Soysal SD, Lohsiriwat V, Kovacs T, Tansley A, Wyld L, Romics L, El-Tamer M, Pusic AL, Sacchini V, Gnant M.

Breast Cancer Res Treat. 2018 Dec;172(3):523-537. doi: 10.1007/s10549-018-4937-1. Epub 2018 Sep 4. Review.

PMID:
30182349
5.

Perspectives on preoperative systemic treatment and breast conservative surgery: One step forward or two steps back?

Rubio IT, Wyld L, Cardoso F, Curigliano G, Kovacs T, Poortmans P, Cortes J.

Breast. 2018 Oct;41:133-135. doi: 10.1016/j.breast.2018.07.008. Epub 2018 Jul 23.

PMID:
30056250
6.

Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysis.

Valachis A, Mamounas EP, Mittendorf EA, Hayashi N, Ishitobi M, Natoli C, Fitzal F, Rubio IT, Tiezzi DG, Shin HC, Anderson SJ, Hunt KK, Matsuda N, Ohsumi S, Totomi A, Nilsson C.

Cancer. 2018 Jul 15;124(14):2923-2930. doi: 10.1002/cncr.31518. Epub 2018 May 3.

PMID:
29723396
7.

RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer.

Cruz C, Castroviejo-Bermejo M, Gutiérrez-Enríquez S, Llop-Guevara A, Ibrahim YH, Gris-Oliver A, Bonache S, Morancho B, Bruna A, Rueda OM, Lai Z, Polanska UM, Jones GN, Kristel P, de Bustos L, Guzman M, Rodríguez O, Grueso J, Montalban G, Caratú G, Mancuso F, Fasani R, Jiménez J, Howat WJ, Dougherty B, Vivancos A, Nuciforo P, Serres-Créixams X, Rubio IT, Oaknin A, Cadogan E, Barrett JC, Caldas C, Baselga J, Saura C, Cortés J, Arribas J, Jonkers J, Díez O, O'Connor MJ, Balmaña J, Serra V.

Ann Oncol. 2018 May 1;29(5):1203-1210. doi: 10.1093/annonc/mdy099.

8.

Correction to: Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes.

Volders JH, Negenborn VL, Spronk PE, Krekel NMA, Schoonmade LJ, Meijer S, Rubio IT, van den Tol MP.

Breast Cancer Res Treat. 2018 Feb;168(1):13-15. doi: 10.1007/s10549-017-4632-7.

PMID:
29327297
9.

A European, Observational Study of Endocrine Therapy Administration in Patients With an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer.

Bastiaannet E, Charman J, Johannesen TB, Schrodi S, Siesling S, van Eycken L, Walsh PM, Audisio RA, Boelens PG, Rubio IT, Jones N, Lewis J, van de Velde CJH.

Clin Breast Cancer. 2018 Aug;18(4):e613-e619. doi: 10.1016/j.clbc.2017.11.019. Epub 2017 Nov 29.

10.

Variations in the opinion of breast surgeons and radiation oncologist regarding indications for radiation therapy after NSM: The need for prospective studies.

Rubio IT.

Eur J Surg Oncol. 2018 Jan;44(1):3-4. doi: 10.1016/j.ejso.2017.11.020. Epub 2017 Dec 2. No abstract available.

PMID:
29224984
11.

Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes.

Volders JH, Negenborn VL, Spronk PE, Krekel NMA, Schoonmade LJ, Meijer S, Rubio IT, van den Tol MP.

Breast Cancer Res Treat. 2018 Feb;168(1):1-12. doi: 10.1007/s10549-017-4598-5. Epub 2017 Dec 6. Review. Erratum in: Breast Cancer Res Treat. 2018 Jan 11;:.

12.

Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial) : A New Tool to Guide the Excision of the Clipped Node After Neoadjuvant Treatment.

Siso C, de Torres J, Esgueva-Colmenarejo A, Espinosa-Bravo M, Rus N, Cordoba O, Rodriguez R, Peg V, Rubio IT.

Ann Surg Oncol. 2018 Mar;25(3):784-791. doi: 10.1245/s10434-017-6270-z. Epub 2017 Dec 1.

PMID:
29197044
13.

Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.

Cardoso F, Bartlett JMS, Slaets L, van Deurzen CHM, van Leeuwen-Stok E, Porter P, Linderholm B, Hedenfalk I, Schröder C, Martens J, Bayani J, van Asperen C, Murray M, Hudis C, Middleton L, Vermeij J, Punie K, Fraser J, Nowaczyk M, Rubio IT, Aebi S, Kelly C, Ruddy KJ, Winer E, Nilsson C, Dal Lago L, Korde L, Benstead K, Bogler O, Goulioti T, Peric A, Litière S, Aalders KC, Poncet C, Tryfonidis K, Giordano SH.

Ann Oncol. 2018 Feb 1;29(2):405-417. doi: 10.1093/annonc/mdx651.

PMID:
29092024
14.

Erratum to: Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients.

Ahmed M, Jozsa F, Baker R, Rubio IT, Benson J, Douek M.

Breast Cancer Res Treat. 2017 Nov;166(2):337. doi: 10.1007/s10549-017-4457-4. No abstract available.

PMID:
28856616
15.

Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients.

Ahmed M, Jozsa F, Baker R, Rubio IT, Benson J, Douek M.

Breast Cancer Res Treat. 2017 Nov;166(2):329-336. doi: 10.1007/s10549-017-4405-3. Epub 2017 Jul 28. Review. Erratum in: Breast Cancer Res Treat. 2017 Nov;166(2):337.

16.

Global Forum of Cancer Surgeons: Declaration of Intent.

Are C, Coit DG, McMasters KM, Giuliano AE, Anderson BO, Balch CM, Pathak KA, Audisio RA, Rubio IT, Gonzalez-Moreno S, Mori M, Eguchi H, Savant D, Prasad BKCM, Cheema MA, Chaudhry ZA, Yang HK, Park DJ, Coimbra FJF, Quadros C, Said HM, Bargallo-Rocha JE.

Ann Surg Oncol. 2017 Sep;24(9):2429-2431. doi: 10.1245/s10434-017-5951-y. Epub 2017 Jul 5. No abstract available.

PMID:
28676922
17.

Breast implant associated anaplastic large cell lymphoma: Impact and implications.

Wyld L, Rubio IT.

Eur J Surg Oncol. 2017 Aug;43(8):1383-1384. doi: 10.1016/j.ejso.2017.06.001. Epub 2017 Jun 12. No abstract available.

PMID:
28634013
18.

Role of total tumour load of sentinel lymph node on survival in early breast cancer patients.

Peg V, Sansano I, Vieites B, Bernet L, Cano R, Córdoba A, Sancho M, Martín MD, Vilardell F, Cazorla A, Espinosa-Bravo M, Pérez-García JM, Cortés J, Rubio IT, Ramón Y Cajal S.

Breast. 2017 Jun;33:8-13. doi: 10.1016/j.breast.2017.02.011. Epub 2017 Feb 28.

19.

Intraoperative assessment of sentinel lymph node by one-step nucleic acid amplification in breast cancer patients after neoadjuvant treatment reduces the need for a second surgery for axillary lymph node dissection.

Espinosa-Bravo M, Navarro-Cecilia J, Ramos Boyero M, Diaz-Botero S, Dueñas Rodríguez B, Luque López C, Ramos Grande T, Ruano Perez R, Peg V, Rubio IT.

Breast. 2017 Feb;31:40-45. doi: 10.1016/j.breast.2016.10.002. Epub 2016 Nov 2.

PMID:
27810698
20.

Meta-analysis of aberrant lymphatic drainage in recurrent breast cancer.

Ahmed M, Baker R, Rubio IT.

Br J Surg. 2016 Nov;103(12):1579-1588. doi: 10.1002/bjs.10289. Epub 2016 Sep 6. Review.

PMID:
27598038
21.

Modeling anti-IL-6 therapy using breast cancer patient-derived xenografts.

Morancho B, Zacarías-Fluck M, Esgueva A, Bernadó-Morales C, Di Cosimo S, Prat A, Cortés J, Arribas J, Rubio IT.

Oncotarget. 2016 Oct 18;7(42):67956-67965. doi: 10.18632/oncotarget.11815.

22.

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

Cardoso F, van't Veer LJ, Bogaerts J, Slaets L, Viale G, Delaloge S, Pierga JY, Brain E, Causeret S, DeLorenzi M, Glas AM, Golfinopoulos V, Goulioti T, Knox S, Matos E, Meulemans B, Neijenhuis PA, Nitz U, Passalacqua R, Ravdin P, Rubio IT, Saghatchian M, Smilde TJ, Sotiriou C, Stork L, Straehle C, Thomas G, Thompson AM, van der Hoeven JM, Vuylsteke P, Bernards R, Tryfonidis K, Rutgers E, Piccart M; MINDACT Investigators.

N Engl J Med. 2016 Aug 25;375(8):717-29. doi: 10.1056/NEJMoa1602253.

23.

The cancer stem-cell signaling network and resistance to therapy.

Carnero A, Garcia-Mayea Y, Mir C, Lorente J, Rubio IT, LLeonart ME.

Cancer Treat Rev. 2016 Sep;49:25-36. doi: 10.1016/j.ctrv.2016.07.001. Epub 2016 Jul 9. Review.

PMID:
27434881
24.

Different Prognostic Implications of Residual Disease After Neoadjuvant Treatment: Impact of Ki 67 and Site of Response.

Diaz-Botero S, Espinosa-Bravo M, Gonçalves VR, Esgueva-Colmenarejo A, Peg V, Perez J, Cortes J, Rubio IT.

Ann Surg Oncol. 2016 Nov;23(12):3831-3837. Epub 2016 Jun 29.

PMID:
27357178
25.

Intraoperative ultrasound guided breast surgery: paving the way for personalized surgery.

Espinosa-Bravo M, Rubio IT.

Gland Surg. 2016 Jun;5(3):366-8. doi: 10.21037/gs.2016.03.06. No abstract available.

26.

Clinical utility of Axillary Reverse Mapping (ARM) in an era of changing perceptions concerning axillary surgery.

Luiten EJ, Beek MA, Rubio IT.

Eur J Surg Oncol. 2016 May;42(5):585-7. doi: 10.1016/j.ejso.2016.01.022. Epub 2016 Feb 10. No abstract available.

PMID:
26898840
27.

Margins in breast conserving surgery: A practice-changing process.

Rubio IT, Ahmed M, Kovacs T, Marco V.

Eur J Surg Oncol. 2016 May;42(5):631-40. doi: 10.1016/j.ejso.2016.01.019. Epub 2016 Feb 3. Review.

PMID:
26880017
28.

Sentinel lymph node biopsy after neoadjuvant treatment in breast cancer: Work in progress.

Rubio IT.

Eur J Surg Oncol. 2016 Mar;42(3):326-32. doi: 10.1016/j.ejso.2015.11.018. Epub 2015 Dec 17. Review.

PMID:
26774943
29.

Sentinel lymph node metastasis after neoadjuvant treatment in breast cancer: Any size matters?

Rubio IT.

World J Clin Oncol. 2015 Dec 10;6(6):202-6. doi: 10.5306/wjco.v6.i6.202.

30.

Systematic review of axillary reverse mapping in breast cancer.

Ahmed M, Rubio IT, Kovacs T, Klimberg VS, Douek M.

Br J Surg. 2016 Feb;103(3):170-8. doi: 10.1002/bjs.10041. Epub 2015 Dec 10. Review.

PMID:
26661686
31.

Intraoperative Ultrasound-Guided Lumpectomy Versus Mammographic Wire Localization for Breast Cancer Patients After Neoadjuvant Treatment.

Rubio IT, Esgueva-Colmenarejo A, Espinosa-Bravo M, Salazar JP, Miranda I, Peg V.

Ann Surg Oncol. 2016 Jan;23(1):38-43. doi: 10.1245/s10434-015-4935-z. Epub 2015 Oct 29.

PMID:
26514120
32.

Surgical treatment of nonpalpable primary invasive and in situ breast cancer.

Ahmed M, Rubio IT, Klaase JM, Douek M.

Nat Rev Clin Oncol. 2015 Nov;12(11):645-63. doi: 10.1038/nrclinonc.2015.161. Epub 2015 Sep 29. Review.

PMID:
26416152
33.

Patterns of HER2 Gene Amplification and Response to Anti-HER2 Therapies.

Vicario R, Peg V, Morancho B, Zacarias-Fluck M, Zhang J, Martínez-Barriocanal Á, Navarro Jiménez A, Aura C, Burgues O, Lluch A, Cortés J, Nuciforo P, Rubio IT, Marangoni E, Deeds J, Boehm M, Schlegel R, Tabernero J, Mosher R, Arribas J.

PLoS One. 2015 Jun 15;10(6):e0129876. doi: 10.1371/journal.pone.0129876. eCollection 2015.

34.

Effect of cellular senescence on the growth of HER2-positive breast cancers.

Zacarias-Fluck MF, Morancho B, Vicario R, Luque Garcia A, Escorihuela M, Villanueva J, Rubio IT, Arribas J.

J Natl Cancer Inst. 2015 May 13;107(5). pii: djv020. doi: 10.1093/jnci/djv020. Print 2015 May.

PMID:
25972601
35.

Surgery improves survival in elderly with breast cancer. A study of 465 patients in a single institution.

Cortadellas T, Córdoba O, Gascón A, Haladjian C, Bernabeu A, Alcalde A, Esgueva A, Rodriguez-Revuelto R, Espinosa-Bravo M, Díaz-Botero S, Xercavins J, Rubio IT, Gil-Moreno A.

Eur J Surg Oncol. 2015 May;41(5):635-40. doi: 10.1016/j.ejso.2015.01.027. Epub 2015 Feb 10.

PMID:
25703077
36.

Gene expression-based classifications of fibroadenomas and phyllodes tumours of the breast.

Vidal M, Peg V, Galván P, Tres A, Cortés J, Ramón y Cajal S, Rubio IT, Prat A.

Mol Oncol. 2015 Jun;9(6):1081-90. doi: 10.1016/j.molonc.2015.01.003. Epub 2015 Jan 31.

37.

The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer.

Rubio IT, Diaz-Botero S, Esgueva A, Rodriguez R, Cortadellas T, Cordoba O, Espinosa-Bravo M.

Eur J Surg Oncol. 2015 Jan;41(1):46-51. doi: 10.1016/j.ejso.2014.11.006. Epub 2014 Nov 15.

PMID:
25466980
38.

Effect of p95HER2/611CTF on the response to trastuzumab and chemotherapy.

Parra-Palau JL, Morancho B, Peg V, Escorihuela M, Scaltriti M, Vicario R, Zacarias-Fluck M, Pedersen K, Pandiella A, Nuciforo P, Serra V, Cortés J, Baselga J, Perou CM, Prat A, Rubio IT, Arribas J.

J Natl Cancer Inst. 2014 Sep 24;106(11). pii: dju291. doi: 10.1093/jnci/dju291. Print 2014 Nov.

39.

Nomogram including the total tumoral load in the sentinel nodes assessed by one-step nucleic acid amplification as a new factor for predicting nonsentinel lymph node metastasis in breast cancer patients.

Rubio IT, Espinosa-Bravo M, Rodrigo M, Amparo Viguri Diaz M, Hardisson D, Sagasta A, Dueñas B, Peg V.

Breast Cancer Res Treat. 2014 Sep;147(2):371-80. doi: 10.1007/s10549-014-3108-2. Epub 2014 Aug 28.

PMID:
25164972
40.

Breast conservative surgery in breast cancer: simple can be harder than complex.

Rubio IT.

J Surg Oncol. 2014 Jul;110(1):1. doi: 10.1002/jso.23638. Epub 2014 May 24. No abstract available.

PMID:
24863457
41.

Detection of sentinel lymph node in breast cancer recurrence may change adjuvant treatment decision in patients with breast cancer recurrence and previous axillary surgery.

Cordoba O, Perez-Ceresuela F, Espinosa-Bravo M, Cortadellas T, Esgueva A, Rodriguez-Revuelto R, Peg V, Reyes V, Xercavins J, Rubio IT.

Breast. 2014 Aug;23(4):460-5. doi: 10.1016/j.breast.2014.03.007. Epub 2014 Apr 13.

PMID:
24726837
42.

Breast-conservative surgery followed by radiofrequency ablation of margins decreases the need for a second surgical procedure for close or positive margins.

Rubio IT, Landolfi S, Molla M, Cortes J, Xercavins J.

Clin Breast Cancer. 2014 Oct;14(5):346-51. doi: 10.1016/j.clbc.2014.02.002. Epub 2014 Feb 21.

PMID:
24703804
43.

Changes in breast cancer reports after pathology second opinion.

Marco V, Muntal T, García-Hernandez F, Cortes J, Gonzalez B, Rubio IT.

Breast J. 2014 May-Jun;20(3):295-301. doi: 10.1111/tbj.12252. Epub 2014 Apr 2.

PMID:
24689830
44.

Factors affecting surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial.

Criscitiello C, Azim HA, de Azambuja E, Rubio IT.

Ann Oncol. 2014 Apr;25(4):910-1. doi: 10.1093/annonc/mdu034. No abstract available.

PMID:
24667722
45.

Lymphatic mapping could not be impaired in the presence of breast carcinoma and coexisting small lymphocytic lymphoma.

Arana S, Vasquez-Del-Aguila J, Espinosa-Bravo M, Peg V, Rubio IT.

Am J Case Rep. 2013 Aug 21;14:322-5. doi: 10.12659/AJCR.884000. eCollection 2013.

46.

Surgery improves breast cancer-specific survival in octogenarians with early-stage breast cancer.

Cortadellas T, Gascón A, Córdoba O, Rabasa J, Rodríguez R, Espinosa-Bravo M, Esgueva A, Rubio IT, Xercavins J, Gil A.

Int J Surg. 2013;11(7):554-7. doi: 10.1016/j.ijsu.2013.05.032. Epub 2013 May 27.

47.

Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay.

Espinosa-Bravo M, Sansano I, Pérez-Hoyos S, Ramos M, Sancho M, Xercavins J, Rubio IT, Peg V.

Eur J Surg Oncol. 2013 Jul;39(7):766-73. doi: 10.1016/j.ejso.2013.03.011. Epub 2013 Apr 19.

PMID:
23607911
48.

Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients.

Peg V, Espinosa-Bravo M, Vieites B, Vilardell F, Antúnez JR, de Salas MS, Delgado-Sánchez JJ, Pinto W, Gozalbo F, Petit A, Sansano I, Del Mar Téllez M, Rubio IT.

Breast Cancer Res Treat. 2013 May;139(1):87-93. doi: 10.1007/s10549-013-2524-z. Epub 2013 Apr 11.

PMID:
23576079
49.

Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial.

Criscitiello C, Azim HA Jr, Agbor-tarh D, de Azambuja E, Piccart M, Baselga J, Eidtmann H, Di Cosimo S, Bradbury I, Rubio IT.

Ann Oncol. 2013 Aug;24(8):1980-5. doi: 10.1093/annonc/mdt129. Epub 2013 Apr 7.

PMID:
23567146
50.

Management of the axilla in early breast cancer patients in the genomic era.

Oliveira M, Cortés J, Bellet M, Balmaña J, De Mattos-Arruda L, Gómez P, Muñoz E, Ortega V, Pérez J, Saura C, Vidal M, Rubio IT, Di Cosimo S.

Ann Oncol. 2013 May;24(5):1163-70. doi: 10.1093/annonc/mds592. Epub 2012 Nov 19. Review.

PMID:
23165977

Supplemental Content

Loading ...
Support Center